Photoactive homomolecular bis(n)-Lophine dyads: Multicomponent synthesis, photophysical properties, theoretical investigation, docking and interaction studies with biomacromolecules

ESIPT mechanism of triple emission with hydroxy-oxadiazole compound in DMSO: A theoretical reconsideration

The compound in solvents with triple fluorescence feature of excited state intramolecular proton transfer (ESIPT) has a broad prospect in fluorescent probes, dye sensors and molecular synthesis of photosensitive dyes. An ESIPT molecule hydroxy-bis-2,5-disubstituted-1,3,4-oxadiazoles (compound 1a) emits two fluorescence peaks in dichloromethane (DCM) and three fluorescence peaks in dimethyl sulfoxide (DMSO). [Dyes and Pigments 197 (2022) 109927]. Two longer peaks were attributed to enol and keto emission in both solvents and the shortest third peak in DMSO was just attributed simply. However, there is a significant difference in proton affinity between DCM and DMSO solvents which has influence on the position of emission peaks. Therefore, the correctness of this conclusion needs to be further verified. In this research, density functional theory and time-dependent density functional theory method are used to explore ESIPT process. Optimized structures indicate ESIPT occurs through molecular bridge assisted by DMSO. The calculated fluorescence spectra demonstrate two peaks indeed originated from enol and keto in DCM, while interestingly three peaks are originated from enol, keto and intermediate in DMSO. Infrared spectrum, electrostatic potential and potential energy curves further prove existence of three structures. We reveal the mechanisms that compound 1a molecule occurs ESIPT in DCM solvent and undergoes an ESIPT through assisted by DMSO molecular bridge. Additionally, three fluorescence peaks in DMSO are reattributed. Our work is expected to provide an insight for understanding intra- and intermolecular interactions and synthesis of efficient organic lighting-emitting molecule.

Computational evaluation of bioactive compounds from Viscum album (mistletoe) as inhibitors of p63 for pancreatic cancer treatment

Pancreatic ductal adenocarcinoma is an aggressive malignancy usually detectable at the advanced stage, with a 5-year survival rate of less than 8%. It has been reported that a gene called tumor-protein 63 (TP63) is expressed in an aggressive form of pancreatic cancer with a squamous signature. Thus, inhibiting the activity of p63 can be a means of treating and managing PDA. Different studies have shown that plant constituents are rich and can be a promising source for discovering drug candidates. The extract from mistletoe (Viscum album) is known to contain anticancer compounds; however, the specific molecular mechanism of the bioactive compounds is unknown. This study examines the pancreatic cancer therapeutic potential of the bioactive compounds in the flavonoid and phenolic acid constituents of mistletoe by adopting structural bioinformatics and advanced theoretical chemistry techniques via molecular docking, molecular dynamics simulation, molecular mechanics/generalized Born surface area (MM/GBSA) calculations, pharmacokinetic analysis, and density functional theory analysis. The six best compounds from the flavonoid constituent with the highest binding affinity ranging from -6.8 kcal/mol to -6.7 kcal/mol were selected with the control gemcitabine (-5.5 kcal/mol) for further computational analysis after molecular docking. Furthermore, MM/GBSA calculation showed the highest binding energy for the selected docked compounds, which validates their inhibitory potential. Hence, the molecular dynamics simulation, post-simulation analysis, pharmacokinetics model, and DFT results showed that mistletoe compounds are reliable due to their stable interaction with the target protein and drug-likeness properties.Communicated by Ramaswamy H. Sarma.

Affinity binding of COVID-19 drug candidates (chloroquine/hydroxychloroquine) and serum albumin: Based on photochemistry and molecular docking

Chloroquine (CQ) and hydroxychloroquine (HCQ) show good efficacy in the treatment of SARS-CoV-2 in the early stage, while they are no longer recommended due to their side effects. As an important drug delivery carrier, serum albumin (SA) is closely related to the efficacy of drugs. Here, the affinity behaviour of chloroquine and hydroxychloroquine with two SA were investigated through the multispectral method of biochemistry and computer simulation. The results showed that the intrinsic emission of both SA was quenched by CQ and HCQ in a spontaneous exothermic entropy reduction static process, which relied mainly on hydrogen bonding and van der Waals forces. The lower binding constants suggested weak binding between the two drugs and SA, which might lead to differences in efficacy and possibly even to varying side effects. Binding site recognition demonstrated that CQ preferred to bind to the two sites of both SA, while HCQ tended to bind to site I of SA. The results of conformational studies demonstrated that CQ and HCQ could affect the structure of both SA by slightly increasing the α-helix content of SA. Finally, we combine the results from experimental start with molecular simulations to suggest drug modifications to guide the design of drugs. This work has important implications for guiding drug design improvements to select CQ derivatives with fewer side effects for the treatment of COVID-19.

Effects of Substituents on the Photophysical/Photobiological Properties of Mono-Substituted Corroles

The trans-A₂B-corrole series was prepared starting with 5-(pentafluorophenyl)dipyrromethene, which was then reacted with respective aryl-substituted aldehyde by Gryko synthesis. It was further characterized by HRMS and electrochemical methods. In addition, we investigated experimental photophysical properties (absorption, emission by steady-state and time-resolved fluorescence) in several solvents and TDDFT calculations, aggregation, photostability and reactive oxygen species generation (ROS), which are relevant when selecting photosensitizers used in photodynamic therapy and many other photo-applications. In addition, we also evaluated the biomolecule-binding properties with CT-DNA and HSA by spectroscopy, viscometry and molecular docking calculations assays.